Maminata Traore-Coulibaly
Koudougou, Burkina Faso
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cytokine-Driven Immune Phenotypes at Delivery as Indicators of Malaria Infection Among Primigravidae in Burkina Faso: An Exploratory Analysis.
Journal: Tropical medicine and infectious disease
Published: December 23, 2025
The clinical significance of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios in malaria infection and parasitaemia among pregnant women in Nanoro, Burkina Faso.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Published: June 30, 2025
Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine-artesunate in a rural health district in Burkina Faso.
Journal: Pharmacology research & perspectives
Published: September 30, 2021
Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol.
Journal: Pilot and feasibility studies
Published: January 02, 2021
Age-modified factors associated with placental malaria in rural Burkina Faso.
Journal: BMC pregnancy and childbirth
Published: November 27, 2020
Genetic variation in the immune system and malaria susceptibility in infants: a nested case-control study in Nanoro, Burkina Faso.
Journal: Malaria journal
Published: March 30, 2020
Fetal biometry assessment with Intergrowth 21st's and Salomon's equations in rural Burkina Faso.
Journal: BMC pregnancy and childbirth
Published: November 14, 2019
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso.
Journal: Patient preference and adherence
Published: March 19, 2019
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial.
Journal: Wellcome open research
Published: February 15, 2019
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life.
Journal: The Journal of infectious diseases
Published: January 03, 2018
Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso.
Journal: Biomarker research
Published: August 30, 2017
Last Updated: 09/26/2026